Abstract

Complex etiology makes cancer a primary cause of death and morbidity. Traditional cancer treatments include chemo, radiation, targeted, and immunotherapy. Although non-specificity, cytotoxicity, and multi-drug tolerance limit cancer treatment. Nanotechnology has transformed cancer diagnosis and treatment. Biocompatibility, lowered toxicity, stability, permeability, retention, and targeted precision make nanoparticles (1-100nm) effective cancer treatments. Nanoparticle kinds vary. Patients’ tumor and tumor environment characteristics determine the nanoparticle medicine delivery device. Nanoparticles revolutionize cancer treatment by reducing adverse effects and overcoming multidrug resistance. New multidrug resistance routes have spurred nanoparticle research. Nano formulations have opened new cancer treatment avenues. Fewer nanodrugs have been approved, and most research is in vitro and in vivo. Nanoparticles, targeting methods, and authorized nanotherapeutics are examined for cancer treatment. We conclude with clinical translation’s pros and downsides.

Keywords:Cancer; Nanoparticles; Formulation